Association between low blood plasmalogen levels, dementia, and mortality

July 27, 2016

Dr. Dayan Goodenowe describes the association between low blood plasmalogen levels, dementia, and mortality

On July 26, 2016, Dr. Dayan Goodenowe, founder of Prodrome Sciences Inc., presented longitudinal research results from 1262 elderly persons that were followed for up to six years at the Alzheimer’s Association International Conference in Toronto, Canada. Non-demented persons with low blood plasmalogen levels had a higher odds of becoming demented within the next 3.7 years than non-demented persons with high blood plasmalogen levels. In addition, persons with low blood plasmalogen levels had a higher odds of dying than persons with high blood plasmalogens, regardless of their cognitive state. Finally, 1134 elderly persons with no dementia were followed for up to six years. At the end of the follow-up period, new cases of dementia were 80% lower in persons with high blood plasmalogens.

Plasmalogens are a type of lipid (fat) that your body uses to keep cellular membranes in good working order. They are especially important for neurons in your brain. When your membranes do not have enough of these lipid molecules, they become rigid and stop functioning properly. Dr. Goodenowe is the inventor of several patents relating to the role of plasmalogens in neurodegenerative diseases. 

Contact us for more information.

About Prodrome Sciences Inc.

Prodrome Sciences researches prodromes of diseases – how to detect them, what causes them, and how to return high-risk prodrome states back to a healthy state before the disease develops. We use our advanced diagnostic technology for blood tests to detect disease prodromes and in our natural therapeutic programs to restore an unhealthy, high-risk prodrome state to a healthy, low-risk state. Our goal is to reduce the number of people that develop and die from disease and to promote optimal health.

Keep in touch

©2018 Prodrome Sciences Inc.

Search